XML 33 R21.htm IDEA: XBRL DOCUMENT v3.20.2
15. SEGMENT REPORTING
 9 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
SEGMENT REPORTING

The management of the Company considers the business to have two operating segments (i) the development of the Bio-RFID™” and “ChromaID™” technologies; (ii) Particle, Inc. technology; and (iii) TransTech, a distributor of products for employee and personnel identification and authentication. TransTech has historically provided substantially all of the Company’s revenues. TransTech was shut down on June 30, 2020. Particle just commenced operations in the quarter ended June 30, 2020.

 

The reporting for the three and nine months ended June 30, 2020 and 2019 was as follows (in thousands):

 

                Segment        
          Gross     Operating     Segment  

Segment

   Revenue     Margin     Profit (Loss)     Assets  
Three Months Ended June 30, 2020                        
Development of the Bio-RFID™” and “ChromaID™” technologies   $ -     $ -     $ (932 )   $ 4,894  
Particle, Inc. technology     -       -       (75 )     146  
TransTech distribution business     -       -       (2 )     -  
Total segments   $ -     $ -     $ (1,009 )   $ 5,040  
                                 
Three Months Ended June 30, 2019                                
Development of the Bio-RFID™” and “ChromaID™” technologies   $ -     $ -     $ (980 )   $ 3,150  
TransTech distribution business     381       105       (45 )     173  
Total segments   $ 381     $ 105     $ (1,025 )   $ 3,323  

 

                Segment        
          Gross     Operating     Segment  

Segment

   Revenue     Margin     Profit (Loss)     Assets  
Nine Months Ended June 30, 2020                        
Development of the Bio-RFID™” and “ChromaID™” technologies   $ -     $ -     $ (4,368 )   $ 4,894  
Particle, Inc. technology     -       -       (75 )     146  
TransTech distribution business     122       52       4       -  
Total segments   $ 122     $ 52     $ (4,439 )   $ 5,040  
                                 
Nine Months Ended June 30, 2019                                
Development of the Bio-RFID™” and “ChromaID™” technologies   $ -     $ -     $ (2,759 )   $ 3,150  
TransTech distribution business     1,577       374       (81 )     173  
Total segments   $ 1,577     $ 374     $ (2,840 )   $ 3,323  

 

During the nine months ended June 30, 2020, the Company incurred non-cash expenses of $6,613,451.